259 related articles for article (PubMed ID: 15922864)
1. Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.
Knowles MA; Aveyard JS; Taylor CF; Harnden P; Bass S
Cancer Lett; 2005 Jul; 225(1):121-30. PubMed ID: 15922864
[TBL] [Abstract][Full Text] [Related]
2. DBC2 gene is silenced by promoter methylation in bladder cancer.
Shi Y; Chen JY; Yang J; Li B; Chen ZH; Xiao CG
Urol Oncol; 2008; 26(5):465-9. PubMed ID: 18640857
[TBL] [Abstract][Full Text] [Related]
3. Fez1/lzts1 alterations in gastric carcinoma.
Vecchione A; Ishii H; Shiao YH; Trapasso F; Rugge M; Tamburrino JF; Murakumo Y; Alder H; Croce CM; Baffa R
Clin Cancer Res; 2001 Jun; 7(6):1546-52. PubMed ID: 11410489
[TBL] [Abstract][Full Text] [Related]
4. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
5. Deletion mapping implicates two tumor suppressor genes on chromosome 8p in the development of bladder cancer.
Takle LA; Knowles MA
Oncogene; 1996 Mar; 12(5):1083-7. PubMed ID: 8649800
[TBL] [Abstract][Full Text] [Related]
6. Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder.
Knowles MA; Habuchi T; Kennedy W; Cuthbert-Heavens D
Cancer Res; 2003 Nov; 63(22):7652-6. PubMed ID: 14633685
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of FEZ1/LZTS1 gene with frequent loss of heterozygosity in oral squamous cell carcinomas.
Ono K; Uzawa K; Nakatsuru M; Shiiba M; Mochida Y; Tada A; Bukawa H; Miyakawa A; Yokoe H; Tanzawa H
Int J Oncol; 2003 Aug; 23(2):297-302. PubMed ID: 12851677
[TBL] [Abstract][Full Text] [Related]
8. Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8.
Flanagan JM; Healey S; Young J; Whitehall V; Trott DA; Newbold RF; Chenevix-Trench G
Genes Chromosomes Cancer; 2004 Jul; 40(3):247-60. PubMed ID: 15139003
[TBL] [Abstract][Full Text] [Related]
9. Genetic analysis of the DBC2 gene in gastric cancer.
Cho YG; Choi BJ; Kim CJ; Song JH; Zhang C; Nam SW; Lee JY; Park WS
Acta Oncol; 2008; 47(3):366-71. PubMed ID: 17906984
[TBL] [Abstract][Full Text] [Related]
10. The chromosome 9q genes TGFBR1, TSC1, and ZNF189 are rarely mutated in bladder cancer.
van Tilborg AA; de Vries A; Zwarthoff EC
J Pathol; 2001 May; 194(1):76-80. PubMed ID: 11329144
[TBL] [Abstract][Full Text] [Related]
11. Mutation of the 9q34 gene TSC1 in sporadic bladder cancer.
Hornigold N; Devlin J; Davies AM; Aveyard JS; Habuchi T; Knowles MA
Oncogene; 1999 Apr; 18(16):2657-61. PubMed ID: 10353610
[TBL] [Abstract][Full Text] [Related]
12. Infrequent mutation of TRAIL receptor 2 (TRAIL-R2/DR5) in transitional cell carcinoma of the bladder with 8p21 loss of heterozygosity.
Adams J; Cuthbert-Heavens D; Bass S; Knowles MA
Cancer Lett; 2005 Apr; 220(2):137-44. PubMed ID: 15766588
[TBL] [Abstract][Full Text] [Related]
13. LAPSER1: a novel candidate tumor suppressor gene from 10q24.3.
Cabeza-Arvelaiz Y; Thompson TC; Sepulveda JL; Chinault AC
Oncogene; 2001 Oct; 20(46):6707-17. PubMed ID: 11709705
[TBL] [Abstract][Full Text] [Related]
14. Reduced FEZ1/LZTS1 expression and outcome prediction in lung cancer.
Nonaka D; Fabbri A; Roz L; Mariani L; Vecchione A; Moore GW; Tavecchio L; Croce CM; Sozzi G
Cancer Res; 2005 Feb; 65(4):1207-12. PubMed ID: 15735004
[TBL] [Abstract][Full Text] [Related]
15. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.
van Tilborg AA; Groenfeld LE; van der Kwast TH; Zwarthoff EC
Br J Cancer; 1999 May; 80(3-4):489-94. PubMed ID: 10408858
[TBL] [Abstract][Full Text] [Related]
16. Mutation and expression analysis of LZTS1 in ovarian cancer.
Arnold JM; Choong DY; Lai J; Campbell IG; Chenevix-Trench G
Cancer Lett; 2006 Feb; 233(1):151-7. PubMed ID: 15876481
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures.
Toyooka S; Fukuyama Y; Wistuba II; Tockman MS; Minna JD; Gazdar AF
Clin Cancer Res; 2002 Jul; 8(7):2292-7. PubMed ID: 12114433
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity analysis and DNA copy number measurement on 8p in bladder cancer reveals two mechanisms of allelic loss.
Adams J; Williams SV; Aveyard JS; Knowles MA
Cancer Res; 2005 Jan; 65(1):66-75. PubMed ID: 15665280
[TBL] [Abstract][Full Text] [Related]
20. Analysis of alterations of WFDC1, a new putative tumour suppressor gene, in hepatocellular carcinoma.
Saffroy R; Riou P; Soler G; Azoulay D; Emile JF; Debuire B; Lemoine A
Eur J Hum Genet; 2002 Apr; 10(4):239-44. PubMed ID: 12032731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
